MAPT and Alzheimer disease: In addition to the APP/PS1 mouse, the Tau/Harlequin double mutant mouse serves as a model to predominantly study mitochondrial dysfunction and human AD-associated tau pathology, as it includes the genetic makeup of the Harlequin mouse, the neurodegenerative aspects of Complex I deficiency, and the tau pathology commonly seen in AD [197].